CVG:FRA
CSPC Pharmaceutical Group Ltd
€0.89
arrow_downward
-0.71%(-0.0064) 1D
බක් 29, 08.04.00 ග්රිමවේ+2 · EUR
search
සියලු සංකේත
1D
5D
1M
6M
YTD
1Y
5Y
උපරි
| සංකේතය | මිල | වෙනස් කිරීම | % වෙනස |
|---|
insights_autoCVG සඳහා ඉහළම ඇතුළාන්තයන් උත්පාදනය කරමින්...
විවෘත කරන්න
€0.89
ඉහළ
€0.89
පහළ
€0.89
වෙ.පො ප්රාග්ධනය
බි96.79
දළ පරිමාව
307.00
හඬ පරිමාණය
0.00
සති-52 ඉහළ
€1.25
සති-52 පහළ
€0.63
සේවකයින් ගණන
ද20
පුවත් සහ කථා
වෙබය හරහා මූලාශ්ර වෙතින්
TipRanks
·
පැය 6කට පෙර
CSPC Wins U.S. and China Trial Approvals for New Oncology Antibody-Drug Conjugate
TipRanks
·
පැය 6කට පෙර
CSPC Wins Historic EU Approval for Chinese-Made Liposomal Antifungal
පැතිකඩ
CSPC Pharmaceutical Group researches, develops, manufactures and sells pharmaceutical products. Its headquarters is in China's Hebei Province.
CSPC produces both active pharmaceutical ingredient and formulations. API products include
penicillin, cefalosporins, synthetic vitamins, caffeine and ranitidine. Formulations include antibiotics, butylphthalide and analgesics, in addition to nearly 1,000 other products.
CSPC's 15,000 employees are divided among more than ten subsidiaries, including CSPC Zhongrun, Weisheng, Zhongnuo and NBP.
CSPC Pharma's total assets are valued above RMB 8 billion. In 2007, CSPC Pharma achieved sales of RMB 8 billion and net income of RMB 485 million. Direct exports of US$300 million ranked CSPC first among China's pharmaceutical enterprises.
One subsidiary, China Pharmaceutical Group Co., Ltd is based in Hong Kong. It is listed on the Hang Seng China-Affiliated Corporations Index. In 2003 and 2004, China Pharma was listed as one of 100 excellent listed companies with turnover less than $1 billion.
CSPC Pharma is recognized as one of China's “500 Most Valuable Chinese Brands” and “Top 500 Chinese Enterprises.” Wikipedia
CSPC Pharmaceutical Group Ltd ගැන
AI අන්තර්ගතයේ වැරදි ඇතුළත් විය හැක. තව දැන ගන්න